Global Innovative Platforms Inc.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Global Innovative Platforms
Surgical & Medical Instruments & Apparatus, SIC 3841
Global Innovative Platforms Inc. is a medical technology company developing non-invasive diagnostic tools that use breath analysis and air quality monitoring to detect animal diseases and assess treatment effectiveness. Its primary focus is creating a canine breath test to identify heartworm infections across early and mature stages, with additional capabilities to monitor therapy response and detect conditions across other animals and agriculture. The company utilizes proprietary gas chromatography devices, specifically the VOCAM Plus and FROG, paired with cloud-based artificial intelligence software to rapidly analyze volatile organic compound patterns without requiring blood samples or needle sticks.
The company operates primarily within the United States animal healthcare market and maintains its principal executive offices in Sanford, Florida, within the Orlando area. It utilizes laboratory operations in Florida while engaging external partner laboratories situated in New Mexico and Oklahoma to process forecasted breath samples and conduct pre-commercialization studies.
Summary of the business section of Global Innovative Platforms's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Global Innovative Platforms Inc.
- Headquarters
- Maitland, FL
- Address
- 149 James Place 32751
- Phone
- (321) 230-3739
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- September 30
- Auditor
- CNGSN & Associates LLP, Bangalore, India
Stock & identifiers
- Ticker
- GIPL
- Exchange
- OTC
- IPO date
- Dec 23, 2003
- Shares outstanding
- 50M, Aug 4, 2026
- Public float
- $2.64M, Sep 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-2000 reverse, Dec 30, 2020; 1-for-8500 reverse, Jan 16, 2015
- SEC CIK
- 1837774
- CUSIP
- 13767J104
- ISIN
- US13767J1043
- EIN
- 85-3816149
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Andrew Nicholas Brown | CEO and CFO, Director | 11,153,366 |
| Elyssa Jacob Campbell | Director | 220,000 |
| Ernest Anthony Porter | Director | – |
| David Michael Mauer | Director | 20,000 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 18, 2026 | Late filing | Notification of late filing |
| Dec 30, 2025 | Late filing | Notification of late filing |
| Nov 7, 2025 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Aug 15, 2025 | Late filing | Notification of late filing |
| Dec 30, 2022 | Late filing | Notification of late filing |
| May 17, 2022 | Late filing | Notification of late filing |
| Feb 15, 2022 | Late filing | Notification of late filing |
| Jan 3, 2022 | Late filing | Notification of late filing |
| Sep 10, 2021 | Name change | Name changed from Canning Street Corp to Global Innovative Platforms Inc. |
| Aug 17, 2021 | Late filing | Notification of late filing |
| May 18, 2021 | Late filing | Notification of late filing |